CompaniesInterpares Biomedicine

Interpares Biomedicine

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

18

By Phase

PHASE1: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
Today
NCT04032717
Hover over trial bars to see details

Recent Trials

NCT04032717Collaborator
Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)
PHASE1Terminated
18 participants
Started: Jul 10, 2019 · Completed: Feb 4, 2021
Related Companies
Clarified Precision Medicine
acquired
Interpares Biomedicine | Biotech Hunter | Biotech Hunter